Compare Stocks: AMDA, LUNG, KEQU, and LNSR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMDA Amedica	$2.70 +1.5%	$0.26	$0.18 ▼ $6.40	$32.05M	-1.24	1.07 million shs	21,443 shs
KEQU Kewaunee Scientific	$37.78 -0.5%	$36.54	$33.27 ▼ $58.95	$108.92M	0.72	2,799 shs	1,733 shs
LNSR LENSAR	$8.30 -1.9%	$6.44	$4.95 ▼ $12.94	$103.94M	0.89	213,304 shs	142,330 shs
LUNG Pulmonx	$2.38 -1.7%	$1.73	$1.13 ▼ $2.89	$103.93M	0.28	718,361 shs	277,209 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMDA Amedica	0.00%	0.00%	0.00%	0.00%	-29.04%
KEQU Kewaunee Scientific	-0.50%	+1.92%	+3.17%	-7.30%	-32.35%
LNSR LENSAR	-1.89%	-4.38%	+58.10%	+43.10%	-31.91%
LUNG Pulmonx	-1.65%	+5.31%	+90.40%	+44.24%	+27.96%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMDA Amedica	$2.70 +1.5%	$0.26	$0.18 ▼ $6.40	$32.05M	-1.24	1.07 million shs	21,443 shs
KEQU Kewaunee Scientific	$37.78 -0.5%	$36.54	$33.27 ▼ $58.95	$108.92M	0.72	2,799 shs	1,733 shs
LNSR LENSAR	$8.30 -1.9%	$6.44	$4.95 ▼ $12.94	$103.94M	0.89	213,304 shs	142,330 shs
LUNG Pulmonx	$2.38 -1.7%	$1.73	$1.13 ▼ $2.89	$103.93M	0.28	718,361 shs	277,209 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMDA Amedica	0.00%	0.00%	0.00%	0.00%	-29.04%
KEQU Kewaunee Scientific	-0.50%	+1.92%	+3.17%	-7.30%	-32.35%
LNSR LENSAR	-1.89%	-4.38%	+58.10%	+43.10%	-31.91%
LUNG Pulmonx	-1.65%	+5.31%	+90.40%	+44.24%	+27.96%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMDA Amedica	0.00	N/A	N/A	N/A
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
LNSR LENSAR	2.33	Hold	$11.50	38.55% Upside
LUNG Pulmonx	2.50	Moderate Buy	$7.67	222.13% Upside

Current Analyst Ratings Breakdown

Latest AMDA, LUNG, KEQU, and LNSR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	LUNG Pulmonx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/21/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/20/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$9.00 ➝ $10.00
8/13/2026	LNSR LENSAR	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
8/13/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $9.00
8/7/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
7/13/2026	LUNG Pulmonx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/30/2026	KEQU Kewaunee Scientific	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)

(Data available from 8/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMDA Amedica	$11.23M	2.85	N/A	N/A	$1.80 per share	1.50
KEQU Kewaunee Scientific	$282M	0.38	$5.92 per share	6.38	$26.80 per share	1.41
LNSR LENSAR	$58.44M	1.75	N/A	N/A	$1.21 per share	6.86
LUNG Pulmonx	$90.50M	1.13	N/A	N/A	$0.91 per share	2.62

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMDA Amedica	-$9.32M	-$3.13	N/A	N/A	N/A	-139.62%	-148.60%	-67.83%	N/A
KEQU Kewaunee Scientific	$9.62M	$3.22	11.73	N/A	N/A	3.41%	14.10%	5.55%	9/9/2026 (Estimated)
LNSR LENSAR	-$34.28M	-$0.33	N/A	N/A	N/A	57.57%	-529.08%	50.03%	11/12/2026 (Estimated)
LUNG Pulmonx	-$54M	-$1.16	N/A	N/A	N/A	-55.03%	-96.66%	-38.32%	11/11/2026 (Estimated)

Latest AMDA, LUNG, KEQU, and LNSR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	LNSR LENSAR	-$0.1650	$0.10	+$0.2650	$0.10	$14.65 million	$16.50 million
7/29/2026	Q2 2026	LUNG Pulmonx	-$0.28	-$0.24	+$0.04	-$0.24	$22.39 million	$22.76 million
6/23/2026	Q4 2026	KEQU Kewaunee Scientific	N/A	$1.14	N/A	$1.13	N/A	$71.40 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMDA Amedica	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
LUNG Pulmonx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMDA Amedica	N/A	1.11	0.99
KEQU Kewaunee Scientific	0.53	2.18	1.55
LNSR LENSAR	N/A	2.39	1.13
LUNG Pulmonx	0.95	4.32	3.52

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMDA Amedica	3.72%
KEQU Kewaunee Scientific	32.69%
LNSR LENSAR	40.15%
LUNG Pulmonx	91.04%

Insider Ownership

Company	Insider Ownership
AMDA Amedica	0.90%
KEQU Kewaunee Scientific	14.10%
LNSR LENSAR	65.80%
LUNG Pulmonx	7.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMDA Amedica	N/A	11.87 million	N/A	Not Optionable
KEQU Kewaunee Scientific	1,231	2.87 million	2.46 million	Not Optionable
LNSR LENSAR	110	12.29 million	4.20 million	Optionable
LUNG Pulmonx	250	42.95 million	39.73 million	Optionable

AMDA, LUNG, KEQU, and LNSR Headlines

Recent News About These Companies

Stonepine Capital Management LLC Purchases New Holdings in Pulmonx Corporation $LUNG

August 28 at 6:23 AM | marketbeat.com

Almitas Capital LLC Buys New Position in Pulmonx Corporation $LUNG

August 28 at 3:12 AM | marketbeat.com

Pulmonx to Participate in Upcoming Investor Conferences

August 27 at 4:05 PM | globenewswire.com

Primecap Management Co. CA Invests $6 Million in Pulmonx Corporation $LUNG

August 27 at 5:27 AM | marketbeat.com

ADAR1 Capital Management LLC Makes New Investment in Pulmonx Corporation $LUNG

August 27 at 3:03 AM | marketbeat.com

Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?

August 26 at 10:55 AM | zacks.com

Parkman Healthcare Partners LLC Takes $841,000 Position in Pulmonx Corporation $LUNG

August 25, 2026 | marketbeat.com

Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year

August 15, 2026 | marketbeat.com

Pulmonx Corp.

August 15, 2026 | cnn.com

What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?

August 14, 2026 | zacks.com

Pulmonx (LUNG) Q2 2026 Earnings Call Transcript

August 8, 2026 | finance.yahoo.com

Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock?

August 3, 2026 | zacks.com

Pulmonx reiterates $90M-$92M 2026 revenue outlook while targeting ~76% gross margin

July 30, 2026 | seekingalpha.com

Pulmonx Target of Unusually Large Options Trading (NASDAQ:LUNG)

July 30, 2026 | marketbeat.com

Pulmonx Corporation (LUNG) Q2 2026 Earnings Call Transcript

July 30, 2026 | seekingalpha.com

Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates

July 29, 2026 | zacks.com

Pulmonx Reports Second Quarter 2026 Financial Results

July 29, 2026 | globenewswire.com

Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

July 28, 2026 | globenewswire.com

Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026

July 15, 2026 | globenewswire.com

Pulmonx (NASDAQ:LUNG) Sparks Fresh Penny Stock Buzz

July 9, 2026 | kalkinemedia.comK

Pulmonx Stock Dividends | NASDAQ:LUNG | Benzinga

June 27, 2026 | benzinga.com

Media Sentiment Over Time

Top Headlines

View All

AMDA, LUNG, KEQU, and LNSR Company Descriptions

Amedica NASDAQ:AMDA

SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.

Kewaunee Scientific NASDAQ:KEQU

$37.78 -0.19 (-0.50%)

As of 08/28/2026 04:00 PM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

LENSAR NASDAQ:LNSR

$8.30 -0.16 (-1.89%)

As of 08/28/2026 04:00 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Pulmonx NASDAQ:LUNG

$2.38 -0.04 (-1.65%)

As of 08/28/2026 04:00 PM Eastern

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMDA, LUNG, KEQU, and LNSR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMDA, LUNG, KEQU, and LNSR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMDA, LUNG, KEQU, and LNSR Headlines

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

AMDA, LUNG, KEQU, and LNSR Company Descriptions

Amedica NASDAQ:AMDA

Kewaunee Scientific NASDAQ:KEQU

LENSAR NASDAQ:LNSR

Pulmonx NASDAQ:LUNG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMDA, LUNG, KEQU, and LNSR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMDA, LUNG, KEQU, and LNSR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMDA, LUNG, KEQU, and LNSR Headlines

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

AMDA, LUNG, KEQU, and LNSR Company Descriptions

Amedica NASDAQ:AMDA

Kewaunee Scientific NASDAQ:KEQU

LENSAR NASDAQ:LNSR

Pulmonx NASDAQ:LUNG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools